Clinical Trials
- HIV/AIDS, Immune System, Infectious Disease
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
- Ages18 years and older
- GenderBoth
- HIV/AIDS
A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)
- Ages18 years and older
- GenderBoth
- HIV/AIDS, Infectious Disease, Tobacco Addiction
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)
- Ages18 years and older
- GenderBoth
- Infectious Disease, COVID-19 Inpatient, COVID-19 Outpatient
Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM (GPS and Health)
- Ages18 years - 34 years
- GenderMale only
- HIV/AIDS
Mechanisms of HIV latency
- Ages18 years and older
- GenderBoth
- Infectious Disease, Men's Health, Women's Health
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults (PRIOH-1)
- Ages16 years and older
- GenderBoth
- Addictive Behavior, HIV/AIDS, Infectious Disease
Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures
- Ages18 years and older
- GenderBoth
- Infectious Disease, Men's Health, Women's Health
EPIC-P Intervention
- Ages18 years and older
- GenderBoth
- Mental Health & Behavioral Research
Project CHANGE: Comprehensive Housing and Addiction Management Network for Greater New Haven
- Ages18 years and older
- GenderBoth
- Alzheimer's
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)
- Ages55 years - 90 years
- GenderBoth